Tasigna Interactions
There are 766 drugs known to interact with Tasigna (nilotinib), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 273 are major, 478 are moderate, and 15 are minor.
- View all 766 medications that may interact with Tasigna
- View Tasigna alcohol/food interactions (1)
- View Tasigna disease interactions (8)
Most frequently checked interactions
View interaction reports for Tasigna (nilotinib) and the medicines listed below.
- albuterol
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- azithromycin
- carvedilol
- Crestor (rosuvastatin)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- furosemide
- gabapentin
- hydrochlorothiazide
- Lasix (furosemide)
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- metoprolol
- Nexium (esomeprazole)
- omeprazole
- oxycodone
- pantoprazole
- prednisone
- Sprycel (dasatinib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Tasigna alcohol/food interactions
There is 1 alcohol/food interaction with Tasigna (nilotinib).
Tasigna disease interactions
There are 8 disease interactions with Tasigna (nilotinib) which include:
- pancreatitis
- QT prolongation
- cardiovascular disease
- fluid retention
- bone marrow suppression
- electrolyte abnormalities
- hepatic impairment
- lactose intolerance
Report options
QR code containing a link to this page
More about Tasigna (nilotinib)
- Tasigna consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
